Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination

Vaccine. 2024 Apr 2;42(9):2455-2462. doi: 10.1016/j.vaccine.2024.03.003. Epub 2024 Mar 10.

Abstract

Background: A wealth of extant research focuses on identifying barriers to, and predictors of, COVID-19 vaccination. In addition to treating COVID-19 vaccination and related experiences as antecedents, this study analyzes the relationships between COVID-19 vaccination experiences and intent to receive the flu, shingles, and HPV vaccines.

Method: Analyses were performed on the responses from U.S. survey panel of 1,024 participants (n = 1,024), 530 (51.8 %) who received at least a dose of the COVID-19 vaccine and 494 (48.2 %) who had not. Descriptive and inferential statistics identify participant demographic characteristics, prior vaccination behavior, vaccination intentions, risk behavior assessment, vaccination attitudes and beliefs, and the predictivity of COVID-19 vaccination, when treated as an antecedent.

Results: Receiving a first dose of the COVID-19 vaccine interacted with receiving a past influenza vaccine, predicting the future intention to receive a COVID-19 vaccine or booster. Vaccine hesitancy in parents is significantly related to vaccination behaviors for themselves and their children. Analyses also showed differences between the vaccinated group (VG) and the unvaccinated group (UVG) on hesitancy, beliefs, and attitudes toward the COVID-19 vaccine.

Conclusion: Experience with COVID-19 vaccination and the relationship of those experiences with other vaccinations provide useful insight on leveraging vaccine uptake. Healthcare professionals should improve the COVID-19 vaccination experience and use vaccination appointments to promote other vaccinations. Research should continue to compare vaccination experiences and how they may persuade or dissuade vaccination intent for other vaccinations.

Keywords: Booster fatigue; COVID-19 vaccine; Cross-vaccine acceptance; HPV, shingles; Vaccine communication; Vaccine risks; Vaccine-hesitancy.

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Child
  • Herpes Zoster*
  • Humans
  • Influenza Vaccines*
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Intention
  • Pandemics / prevention & control
  • Papillomavirus Infections*
  • Papillomavirus Vaccines*
  • Vaccination

Substances

  • Influenza Vaccines
  • COVID-19 Vaccines
  • Papillomavirus Vaccines